Bank of New York Mellon’s CalciMedica CALC Stock Holding History

Bank of New York Mellon’s Portfolio CALC Stock Details CALC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-7,159	Closed	-$50.1K	–	4388
2022 Q4	$50.1K	Sell	7,159 -54	-0.7%	-$606	﹤0.01%	4237
2022 Q3	$95K	Hold	7,213	–	–	﹤0.01%	4207
2022 Q2	$110K	Sell	7,213 -47	-0.6%	-$642	﹤0.01%	4206
2022 Q1	$125K	Buy	+7,260	New	+$138K	﹤0.01%	4359
2021 Q2	–	Sell	-1,303	Closed	-$101K	–	4399
2021 Q1	$101K	Buy	1,303 +137	+12%	+$41K	﹤0.01%	4163
2020 Q4	$473K	Buy	+1,166	New	+$344K	﹤0.01%	3647

Bank of New York Mellon's CALC Position: Q1 2023 in Review

Bank of New York Mellon sold out of CalciMedica (CALC) in Q1 2023, closing a stake of 7,159 shares — an estimated $50.1K sold.

Bank of New York Mellon first reported a position in CALC in Q4 2020 and held it in 6 quarters. The position peaked at $473K in Q4 2020. 0 funds tracked by Wall St. Rank hold CALC as of Q1 2023.

Bank of New York Mellon reported no remaining CalciMedica position as of Q1 2023 after selling out during the quarter.
Bank of New York Mellon sold 7,159 CalciMedica shares in Q1 2023, an estimated $50.1K.
Bank of New York Mellon first reported a position in CalciMedica in Q4 2020 and held it in 6 quarters.
Bank of New York Mellon's CalciMedica position peaked at $473K in Q4 2020.
0 funds tracked by Wall St. Rank held CalciMedica as of Q1 2023.

Based on Bank of New York Mellon's 13F filing for Q1 2023, filed 9 May 2023.